Hain Celestial Group Valuation
Is 0J2I undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0J2I when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0J2I ($8.12) is trading below our estimate of fair value ($29.49)
Significantly Below Fair Value: 0J2I is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0J2I?
Key metric: As 0J2I is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0J2I's PS Ratio? | |
|---|---|
| PS Ratio | 0.4x |
| Sales | US$1.71b |
| Market Cap | US$743.20m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 11.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0J2I's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.8x | ||
BAKK Bakkavor Group | 0.3x | 1.9% | UK£751.9m |
HOTC Hotel Chocolat Group | 2.6x | 5.4% | UK£526.6m |
HFG Hilton Food Group | 0.2x | 3.6% | UK£825.3m |
MHPC MHP | 0.2x | n/a | US$452.8m |
0J2I Hain Celestial Group | 0.4x | 1.5% | US$743.2m |
Price-To-Sales vs Peers: 0J2I is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (0.8x).
Price to Sales Ratio vs Industry
How does 0J2I's PS Ratio compare vs other companies in the GB Food Industry?
Price-To-Sales vs Industry: 0J2I is good value based on its Price-To-Sales Ratio (0.4x) compared to the UK Food industry average (0.8x).
Price to Sales Ratio vs Fair Ratio
What is 0J2I's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.4x |
| Fair PS Ratio | 0.5x |
Price-To-Sales vs Fair Ratio: 0J2I is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$8.12 | US$9.71 +19.6% | 23.2% | US$15.00 | US$8.00 | n/a | 13 |
| Nov ’25 | US$9.18 | US$10.10 +10.0% | 19.8% | US$15.00 | US$8.00 | n/a | 13 |
| Oct ’25 | US$9.15 | US$10.10 +10.4% | 19.8% | US$15.00 | US$8.00 | n/a | 13 |
| Sep ’25 | US$7.89 | US$10.10 +28.1% | 19.8% | US$15.00 | US$8.00 | n/a | 13 |
| Aug ’25 | US$7.51 | US$9.46 +26.1% | 23.3% | US$15.00 | US$7.00 | n/a | 13 |
| Jul ’25 | US$6.99 | US$9.46 +35.5% | 23.3% | US$15.00 | US$7.00 | n/a | 13 |
| Jun ’25 | US$7.79 | US$9.46 +21.5% | 23.3% | US$15.00 | US$7.00 | n/a | 13 |
| May ’25 | US$6.56 | US$11.31 +72.3% | 24.6% | US$18.00 | US$8.00 | n/a | 13 |
| Apr ’25 | US$7.93 | US$12.15 +53.3% | 19.6% | US$18.00 | US$10.00 | n/a | 13 |
| Mar ’25 | US$9.57 | US$12.15 +27.0% | 19.6% | US$18.00 | US$10.00 | n/a | 13 |
| Feb ’25 | US$10.69 | US$13.56 +26.8% | 30.0% | US$25.00 | US$10.00 | n/a | 12 |
| Jan ’25 | US$11.11 | US$13.72 +23.5% | 30.1% | US$25.00 | US$10.00 | n/a | 12 |
| Dec ’24 | US$10.80 | US$13.83 +28.1% | 29.3% | US$25.00 | US$10.00 | n/a | 12 |
| Nov ’24 | US$11.04 | US$14.33 +29.8% | 36.3% | US$30.00 | US$11.00 | US$9.18 | 12 |
| Oct ’24 | US$10.41 | US$15.00 +44.1% | 38.2% | US$30.00 | US$11.00 | US$9.15 | 12 |
| Sep ’24 | US$10.58 | US$15.58 +47.3% | 34.7% | US$30.00 | US$11.00 | US$7.89 | 12 |
| Aug ’24 | US$12.17 | US$16.83 +38.4% | 29.3% | US$30.00 | US$13.00 | US$7.51 | 12 |
| Jul ’24 | US$12.44 | US$17.25 +38.6% | 27.8% | US$30.00 | US$13.00 | US$6.99 | 12 |
| Jun ’24 | US$11.97 | US$18.25 +52.5% | 23.3% | US$30.00 | US$14.00 | US$7.79 | 12 |
| May ’24 | US$17.20 | US$22.85 +32.9% | 29.9% | US$42.00 | US$16.00 | US$6.56 | 13 |
| Apr ’24 | US$16.20 | US$23.00 +42.0% | 30.8% | US$42.00 | US$16.00 | US$7.93 | 12 |
| Mar ’24 | US$17.81 | US$22.77 +27.8% | 30.1% | US$42.00 | US$16.00 | US$9.57 | 13 |
| Feb ’24 | US$20.76 | US$23.15 +11.6% | 30.4% | US$42.00 | US$16.00 | US$10.69 | 13 |
| Jan ’24 | US$16.02 | US$24.79 +54.7% | 28.4% | US$42.00 | US$17.00 | US$11.11 | 14 |
| Dec ’23 | US$18.93 | US$25.96 +37.2% | 27.8% | US$42.00 | US$18.00 | US$10.80 | 13 |
| Nov ’23 | US$19.09 | US$26.42 +38.4% | 29.0% | US$42.00 | US$16.00 | US$11.04 | 13 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Ebro Foods
€2.5b
Operates as a food company in Spain, rest of Europe, the United States, Canada, and internationally.
0NYH
€16.02
7D
0.6%
1Y
1.9%
Nestlé
CHF 195.4b
Operates as a food and beverage company.
NESNZ
CHF 76.36
7D
-1.6%
1Y
-23.9%
KWS SAAT SE KGaA
€2.0b
KWS SAAT SE & Co. KGaA breeds, produces, and distributes seeds for agriculture.
0F1N
€60.10
7D
1.7%
1Y
16.3%